Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI
Michigan State University · NCT07301905
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 265
- US sites recruiting
- 1
- Study start
- November 17, 2024
- Record last updated
- March 13, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to learn if culturally targeted messaging about the human papillomavirus (HPV) increases receptivity to the HPV vaccine among African American parents of vaccine-eligible daughters. The main question it aims to answer is:
- Does culturally targeted messaging increase African American parents' intentions to vaccinate their daughter against HPV?
Research will compare culturally targeted messaging to general, educational messaging and no messaging.
Participants will
- View culturally targeted messages, education-only messages, or no messages about the HPV vaccine
- Report their intentions to vaccinate their daughter against HPV
- Report whether they have initiated HPV vaccination for their daughter six months later
Being studied: General HPV Vaccine Health Messaging; Culturally Targeted HPV Vaccine Health Messaging
Conditions: HPV Vaccination
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Identify as Black/African American or White/Caucasian
- Have at least one daughter who is between 8-17 years of age, who is not currently pregnant, and who has not received any doses of the HPV vaccine
Exclusion Criteria
- N/A
Recruiting US locations
Flint Journal Building
Flint, MI 48502
Site contact: Olivia · 3306126007 · aspiraso@msu.edu
Study contacts (from the official record)
- Olivia Aspiras, PhD · 810-600-9181 · aspiraso@msu.edu
Similar studies in Michigan
All vaccine studies in Michigan →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Allen Park, MI + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Farmington Hills, MI + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 3
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Pfizer
- Location
- Allen Park, MI + 101 other US sites
- Eligibility basics
- Ages 1 mo–7 mo
- RecruitingHealthy volunteersPhase 4
Study of a Recombinant Spike COVID-19 Vaccine With Matrix-M in Older Adults and People at Increased Risk of Severe COVID-19
Sanofi
- Location
- Southfield, MI + 19 other US sites
- Eligibility basics
- Ages 12+